Eris Lifesciences said it has entered into a definitive agreement to acquire Biocon Biologics’ dermatology and nephrology branded formulations business units in India for Rs 366 crore. Eris said the acquisition...
Mankind Pharma and Baidyanath Ayurveda in race for government’s IMPCL
Mankind Pharma and Baidyanath Ayurveda are among the companies that have submitted expressions of interest (EoIs) to acquire 100% of government-owned Ayurveda company Indian Medicines Pharmaceutical Corporation (IMPCL)...
Zydus Lifesciences acquires UK-based LiqMeds Group for Rs 690 crore
Zydus Lifesciences said it has acquired UK-based LiqMeds Group which specialises in oral liquid products for GBP 68 million (Rs 690 crores) in an all cash deal. Zydus will pay an upfront consideration of GBP 68 million...
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy
U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval for its proposed $43 billion acquisition of cancer drug maker Seagen. Pfizer announced the deal in March, its largest purchase in a string of...
Cipla stake sale plan faces hurdle as promoters differ on valuation: Report
The likely Cipla stake sale plan has come across a tricky hurdle as reportedly the promoters are not aligned in view regarding the common valuation. Differences among founders may lead to delay in deal until common...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Bristol-Myers Squibb said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent...
Sanofi to explore acquisition of cancer drugmaker Mirati, Bloomberg reports
Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and there...
US-based Advent seeking investors for Suven-Cohance merger
US-based Advent could rope in new investors into its planned combination of Suven Pharma and Cohance Life Sciences, as it looks to create a top three contract development and manufacturing organisation with a...
IQuest Enterprises acquires Viatris’ Indian API operations
IQuest Enterprises, a multi-sector investment company, said it has entered into a definitive agreement to acquire the API (active pharmaceutical ingredient) operations of global pharmaceutical major Viatris in India...
PE Advent completes acquisition of Suven Pharma, appoints new Board and management team
Private equity firm Advent International announced the completion of its majority acquisition of Hyderabad-based listed contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired 50.1%...
Italy’s Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mln
Italy’s Alfasigma S.p.A agreed on Tuesday to buy drugmaker Intercept Pharmaceuticals for $794 million as it aims to expand its treatment portfolio in liver diseases and digestive system disorders, and bolster...
Novo Holdings, Gurnet Point close $462 million acquisition of Paratek Pharmaceuticals
Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and Gurnet Point Capital on Thursday closed their acquisition of biopharmaceutical company Paratek Pharmaceuticals in a deal worth $462 million, Novo...
